| Chemodosimeters: An approach for detection and estimation of biologically and medically relevant metal ions, anions and thiols K Kaur, R Saini, A Kumar, V Luxami, N Kaur, P Singh, S Kumar Coordination Chemistry Reviews 256 (17-18), 1992-2028, 2012 | 405 | 2012 |
| Synthesis of new conjugated coumarin–benzimidazole hybrids and their anticancer activity K Paul, S Bindal, V Luxami Bioorganic & medicinal chemistry letters 23 (12), 3667-3672, 2013 | 154 | 2013 |
| Chromofluorescent probes for selective detection of fluoride and acetate ions S Kumar, V Luxami, A Kumar Organic letters 10 (24), 5549-5552, 2008 | 136 | 2008 |
| Triazine as a promising scaffold for its versatile biological behavior P Singla, V Luxami, K Paul European journal of medicinal chemistry 102, 39-57, 2015 | 124 | 2015 |
| Benzimidazole-biologically attractive scaffold for protein kinase inhibitors P Singla, V Luxami, K Paul RSC Advances 4 (24), 12422-12440, 2014 | 112 | 2014 |
| Imidazo [1, 2-a] pyridines: Promising drug candidate for antitumor therapy R Goel, V Luxami, K Paul Current Topics in Medicinal Chemistry 16 (30), 3590-3616, 2016 | 93 | 2016 |
| Triazine–benzimidazole hybrids: Anticancer activity, DNA interaction and dihydrofolate reductase inhibitors P Singla, V Luxami, K Paul Bioorganic & medicinal chemistry 23 (8), 1691-1700, 2015 | 93 | 2015 |
| Insights of 8-hydroxyquinolines: A novel target in medicinal chemistry R Gupta, V Luxami, K Paul Bioorganic chemistry 108, 104633, 2021 | 88 | 2021 |
| 1, 8‐Naphthalimide: a potent DNA intercalator and target for cancer therapy R Tandon, V Luxami, H Kaur, N Tandon, K Paul The Chemical Record 17 (10), 956-993, 2017 | 86 | 2017 |
| Colorimetric and ratiometric fluorescence sensing of fluoride ions based on competitive intra-and intermolecular proton transfer V Luxami, S Kumar Tetrahedron letters 48 (17), 3083-3087, 2007 | 84 | 2007 |
| Synthesis and in vitro antitumor evaluation of primary amine substituted quinazoline linked benzimidazole K Paul, A Sharma, V Luxami Bioorganic & Medicinal Chemistry Letters 24 (2), 624-629, 2014 | 80 | 2014 |
| Molecular half-subtractor based on 3, 3′-bis (1 H-benzimidazolyl-2-yl)[1, 1′] binaphthalenyl-2, 2′-diol V Luxami, S Kumar New Journal of Chemistry 32 (12), 2074-2079, 2008 | 76 | 2008 |
| Traceless directing groups: a novel strategy in regiodivergent C–H functionalization G Rani, V Luxami, K Paul Chemical Communications 56 (83), 12479-12521, 2020 | 74 | 2020 |
| Chemodosimeters for optical detection of fluoride anion S Dhiman, M Ahmad, N Singla, G Kumar, P Singh, V Luxami, N Kaur, ... Coordination Chemistry Reviews 405, 213138, 2020 | 73 | 2020 |
| Synthesis and in vitro evaluation of novel triazine analogues as anticancer agents and their interaction studies with bovine serum albumin P Singla, V Luxami, K Paul European Journal of Medicinal Chemistry 117, 59-69, 2016 | 70 | 2016 |
| A fluorescent probe with “AIE+ ESIPT” characteristics for Cu2+ and F− ions estimation AS Gupta, K Paul, V Luxami Sensors and Actuators B: Chemical 246, 653-661, 2017 | 69 | 2017 |
| Recent advances in development of imidazo [1, 2-a] pyrazines: synthesis, reactivity and their biological applications R Goel, V Luxami, K Paul Organic & Biomolecular Chemistry 13 (12), 3525-3555, 2015 | 68 | 2015 |
| Synthesis, single crystal and antitumor activities of benzimidazole–quinazoline hybrids A Sharma, V Luxami, K Paul Bioorganic & medicinal chemistry letters 23 (11), 3288-3294, 2013 | 63 | 2013 |
| Novel pyrazolo [3, 4-d] pyrimidine with 4-(1H-benzimidazol-2-yl)-phenylamine as broad spectrum anticancer agents: Synthesis, cell based assay, topoisomerase inhibition, DNA … P Singla, V Luxami, R Singh, V Tandon, K Paul European journal of medicinal chemistry 126, 24-35, 2017 | 61 | 2017 |
| Syntheses and anti-cancer activities of 2-[1-(indol-3-yl-/pyrimidin-5-yl-/pyridine-2-yl-/quinolin-2-yl)-but-3-enylamino]-2-phenyl-ethanols P Singh, P Kaur, V Luxami, S Kaur, S Kumar Bioorganic & medicinal chemistry 15 (6), 2386-2395, 2007 | 60 | 2007 |
